The early trials confirm an average approximate 10% weight loss, and patients report a significant reduction in appetite and suppression of food cravings and bingeing.
However, like late 2022, we are now facing another shortage of GLP-1 receptor agonists. Patients who had been helped in losing weight are losing the benefits due to being unable to obtain these medications, and again fear that their weight will increase.
These are our suggestions –
Please don’t give up on your program and weight loss journey. Focus on the things you can control – your activity, intake, healthy sleep habits and getting support for your mental health!
We are in an environment where there will be continuing shortages of highly sought-after medications. There are always other options – please see your weight loss team at Brilliant Being.